Investigating the Economic Impact of Mandatory Electronic Prescribing Requirements in the United States
dc.contributor.advisor | Parker, Miriam | |
dc.contributor.author | Kent, Michelle | |
dc.date.accessioned | 2018-09-17T11:08:15Z | |
dc.date.accessioned | 2024-10-29T14:20:13Z | |
dc.date.available | 2018-12-31T22:10:06Z | |
dc.date.available | 2024-10-29T14:20:13Z | |
dc.date.issued | 2017 | |
dc.description | Magister Scientiae - MSc (Pharmacy Administration and Policy Regulation) | |
dc.description.abstract | Technological advancements applied to healthcare may holistically improve the economic burden of prescription medication costs. United States legislative actions requiring utilization of electronic prescribing (e-prescribing) will drive provider utilization to decrease healthcare spending. Federal and state e-prescribe requirements have been met with resistance by the prescribing community, due to claims that the requirements create an economic burden for them. This research intends to demonstrate the long-term economic value of electronic prescribing regulations across the healthcare spectrum. | |
dc.identifier.uri | https://hdl.handle.net/10566/16387 | |
dc.language.iso | en | |
dc.publisher | University of the Western Cape | |
dc.rights.holder | University of the Western Cape | |
dc.subject | Affordable Care Act, Academy of Managed Care Pharmacies, American Pharmacists Association, Center for Biologics Evaluation and Research, Centers for Disease Control and Prevention | |
dc.title | Investigating the Economic Impact of Mandatory Electronic Prescribing Requirements in the United States |
Files
Original bundle
1 - 1 of 1